Annual Total Long Term Liabilities
$30.18 M
+$30.18 M+100.00%
31 December 2023
Summary:
Acumen Pharmaceuticals annual total long term liabilities is currently $30.18 million, with the most recent change of +$30.18 million (+100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$26.47 million (-46.73%). ABOS annual total long term liabilities is now -46.73% below its all-time high of $56.65 million, reached on 31 December 2020.ABOS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$29.86 M
+$260.00 K+0.88%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly total long term liabilities is currently $29.86 million, with the most recent change of +$260.00 thousand (+0.88%) on 30 September 2024. Over the past year, it has increased by +$29.86 million (+100.00%). ABOS quarterly long term liabilities is now -82.89% below its all-time high of $174.50 million, reached on 30 June 2021.ABOS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +100.0% |
| 3 y3 years | -46.7% | +100.0% |
| 5 y5 years | - | - |
ABOS Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -46.7% | -2.0% | ||
| 5 y | 5 years | -46.7% | -82.9% | ||
| alltime | all time | -46.7% | -82.9% |
Acumen Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.86 M(+0.9%) |
| June 2024 | - | $29.60 M(-2.8%) |
| Mar 2024 | - | $30.46 M(+0.9%) |
| Dec 2023 | $30.18 M(>+9900.0%) | $30.18 M(>+9900.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) |
| Sept 2022 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $25.00 K(-59.7%) |
| Mar 2022 | - | $62.00 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(-100.0%) |
| June 2021 | - | $174.50 M(+208.0%) |
| Mar 2021 | - | $56.65 M(0.0%) |
| Dec 2020 | $56.65 M(+225.6%) | - |
| Dec 2020 | - | $56.65 M |
| Dec 2019 | $17.40 M | - |
FAQ
- What is Acumen Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Acumen Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Acumen Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ABOS is $30.18 M
What is the all time high annual total long term liabilities for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual total long term liabilities is $56.65 M
What is Acumen Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ABOS annual total long term liabilities has changed by +$30.18 M (+100.00%)
What is Acumen Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ABOS is $29.86 M
What is the all time high quarterly long term liabilities for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly total long term liabilities is $174.50 M
What is Acumen Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ABOS quarterly total long term liabilities has changed by +$29.86 M (+100.00%)